Nonclinical services for the development of interventional agents for infectious diseases
Active Awarded Last action
- Contract number
- 75N93022F00011
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,950,919
Award facts
- Contract value 100% obligated
- $4,950,919.00 Current and potential, with all options
- Completion date 75% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $4,950,919 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 14, 2022, with a ceiling value of $4.95 million for nonclinical services supporting the development of interventional agents for infectious diseases, under the Nonclinical Services for Development of Interventional Agents parent IDIQ.
Place of performance is Menlo Park, CA. Period of performance extends through March 13, 2028. The order is priced on a cost-plus-fixed-fee basis with no small business set-aside.
Service Contract Inventory reporting shows Sri International invoiced $4 thousand in FY2022 (0.0 FTEs, 12 hours), $526 thousand in FY2023 (0.9 FTEs, 1,915 hours), and $982 thousand in FY2024 (1.3 FTEs, 2,717 hours). Derived government-paid blended hourly rates trended upward across the period: $335.93/hr (FY2022), $274.71/hr (FY2023), and $361.28/hr (FY2024). In FY2024, one subcontractor was engaged on 17 percent of contractor hours.
Quick answers
Who was awarded contract 75N93022F00011?
75N93022F00011 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 14, 2022.
How much is contract 75N93022F00011 worth?
The government has obligated $4,950,919 on 75N93022F00011.
Is contract 75N93022F00011 an order under another contract?
Yes. 75N93022F00011 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00011 competed?
The extent of competition for 75N93022F00011 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award